Tyvaso DPI Approved to Treat High Blood Pressure in the Lungs
May 24, 2022Tibsovo Now Indicated for Newly Diagnosed Acute Myeloid Leukemia
May 25, 2022May 24, 2022 – Vtama® (tapinarof) 1% cream has been approved to treat plaque psoriasis in adults.
- Vtama is the first novel topical treatment for plaque psoriasis to receive FDA approval in 25 years. It is also the first steroid-free topical medication in its class.
- Recommended dosing is a thin layer of cream applied to the affected area once daily.
- Manufacturer Dermavant Sciences has launched the product at a wholesale acquisition cost (WAC) of $1,325 per 60g tube.